Fentanyl Citrate Active Pharmaceutical Ingredient recall: CGMP Deviations
Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856)…
Why was Fentanyl Citrate Active Pharmaceutical Ingredient recalled?
cGMP Deviations: Potential glass contamination
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: B0030-180101, B0030-180102, Exp. Feb 2023
- Product
- Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856)…
- Recalling firm
- Johnson Matthey Inc.
- Quantity
- 52882.23 grams
- Distribution
- Nationwide within the United States
- Recall date
- October 2, 2019
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)